Patent ID: 8969340
Filing Date: 2015-03-03
Classification: A61K,A61P,C12Q,G01N

Abstract:
1. A method of treating a male subject having, or suspected of having, chronic pelvic pain syndrome comprising: treating a subject with an agent that targets MCP-1, MIP-1α, or the CCR-2 receptor, wherein said subject has one or more symptoms of chronic pelvic pain syndrome, wherein said agent is selected from the group consisting of: an indolopiperidine, a spiropiperidine, a 2-substituted indole, a pyrazolone derivative, a 2-substituted benzimidazole, an N,N-dialkylhomopiperazine, a bicyclic pyrrole, a 5-aryl pentadienamide, and a cyclic amine derivative; and wherein said treating is under conditions such that at least one of said symptoms is reduced or eliminated.